i-law

Personal Injury Compensation

Understanding required for consent to puberty supressing hormones

Bell and Another v The Tavistock and Portman NHS Foundation Trust, National Health Service Commissioning Board (NHS England) (Interested Party), University College London Hospitals NHS Foundation Trust, Leeds Teaching Hospitals NHS Trust, Transgender Trend Ltd (Interveners) [2020] EWHC 3274 (Admin)

In a challenge by way of judicial review concerning the provision of medication to suppress puberty, a court has held that a child under 16 could only consent to the use of such medication if he or she had sufficient competence to understand the nature of the treatment, including the immediate and long-term consequences of the treatment, the limited evidence concerning its efficacy or purpose, and its potentially life-changing consequences.

The rest of this document is only available to i-law.com online subscribers.

If you are already a subscriber, click Log In button.

Copyright © 2024 Maritime Insights & Intelligence Limited. Maritime Insights & Intelligence Limited is registered in England and Wales with company number 13831625 and address 5th Floor, 10 St Bride Street, London, EC4A 4AD, United Kingdom. Lloyd's List Intelligence is a trading name of Maritime Insights & Intelligence Limited.

Lloyd's is the registered trademark of the Society Incorporated by the Lloyd's Act 1871 by the name of Lloyd's.